在小血管血管炎 (血管炎呈现为皮肤状) 中,皮肤状的相关性
Zaynab Marzuk1, Yamen Homsi2, Ata S Moshiri3
1Department of Internal Medicine, FHC at NYU Langone Hospital-Brooklyn, Brooklyn, NY, USA.
The American journal of the medical sciences
|August 4, 2025
概括
皮肤质性 (PG) 是一种中性友皮肤病,通常与自身免疫性疾病有关. 这一案例突出了与小血管血管炎相关的独特的PG类病变,该病例已成功用甲醇治疗.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 皮肤病 (PG) 的特点是迅速扩散,疼痛的.
- 在组织学上,PG是一种中性友皮肤病,通常与自身免疫性疾病如血管炎有关.
- 准确的诊断和免疫抑制疗法对于管理PG至关重要.
研究的目的:
- 报告一种独特的皮质性性类病变病例.
- 探索这种病变与小血管血管炎之间的关联.
- 强调在血管炎的背景下识别PG类病变的重要性.
主要方法:
- 一个47岁的男性患者的病例报告.
- 类似PG的病变的临床表现和组织学发现.
- 用甲索特酸治疗和评估病变反应.
主要成果:
- 这位患者呈现出一种独特的皮肤质性状病变.
- 发现病变与小血管血管炎有关.
- 在开始甲状腺素治疗后,观察到病变的显著改善.
结论:
- 类似于皮肤病的病变可能与小血管血管炎有关.
- 甲索特雷克萨治疗可以有效地管理这些病例.
- 认识到这种关联对于适当的患者管理至关重要.
相关概念视频
Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Peptic Ulcer Disease I: Introduction
291
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
291
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
36
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
36
Peptic Ulcer Disease II: Pathophysiology
847
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
847


